2,654
edits
Research Integrity: Difference between revisions
m
no edit summary
(changed Clinical Trial Professional and Technical Fee Billing to Clinical Research and Clinical Trial Professional and Technical Fee Billing so link would be bold and black when on the page) |
mNo edit summary |
||
| Line 17: | Line 17: | ||
<td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Faculty]]</td> | <td style="padding:0.5em; background-color:#e5e5e5; font-size:90%; line-height:0.95em; border:1px solid #A3B1BF; border-bottom:solid 2px #A3B1BF" width="20">[[Faculty]]</td> | ||
</tr> | </tr> | ||
<br /> | <br /> | ||
[[Compliance Program]] | [[Compliance Hotline]] | [[Investigations by Third Parties]] | [[Research Integrity]] | [[Export Control]] | [[Code of Conduct]] | [[Use of Human Anatomical Material]] | [[Clinical Research and Clinical Trial Professional and Technical Fee Billing]] | [[Contracts]] | [[Conflict of Interest]] | [[Red Flag Identity Theft Prevention Program]] | [[Principles of Financial Stewardship]] | [[Human Tissue Use and Transfer]] | [[Disclosing Foreign Support and International Activities]] | [[Health Care Vendor Interactions]] | [[Credit Hour Definition]] | [[Whistleblower]]<br /> | |||
<br /> | <br /> | ||
Policy No.: '''8003'''<br /> | Policy No.: '''8003'''<br /> | ||
| Line 208: | Line 206: | ||
*Contact the [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer]<br /> | *Contact the [mailto:sarah.glodencarlson@unmc.edu Chief Compliance Officer]<br /> | ||
*Contact the [mailto:rzetterm@unmc.edu Research Integrity Officer]<br /> | *Contact the [mailto:rzetterm@unmc.edu Research Integrity Officer]<br /> | ||
This page maintained by [mailto:dpanowic@unmc.edu dkp]. | This page maintained by [mailto:dpanowic@unmc.edu dkp]. | ||